Controlling Impurities in Pharma Waters

Without proper impurity control, pharmaceutical manufacturers risk compromising the safety and efficacy of their products. Microbial and organic impurities can enter water systems at various points in the manufacturing process and impact quality and safety.

Misunderstandings surrounding controlling impurities in pharma waters can lead to improper measurement and treatment approaches.

It is a common belief that organic and microbiological contaminants in Water for Injection (WFI) and Purified Water (PW) are the same in pharmaceutical water systems. However, this is far from the truth. These contaminants react differently and, when found in storage and distribution loops, can have different effects on the health of the water system.